Page last updated: 2024-08-26

1-(2-pyridinyl)piperazine and Acute Confusional Senile Dementia

1-(2-pyridinyl)piperazine has been researched along with Acute Confusional Senile Dementia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choubey, PK; Krishnamurthy, S; Prajapati, SK; Seth, A; Sharma, P; Shrivastava, SK; Tripathi, A; Tripathi, MK; Tripathi, PN1

Other Studies

1 other study(ies) available for 1-(2-pyridinyl)piperazine and Acute Confusional Senile Dementia

ArticleYear
Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Female; Humans; Kinetics; Molecular Docking Simulation; Neuroprotective Agents; Oxadiazoles; Piperazines; Protein Aggregates; Pyridines; Rats, Wistar; Structure-Activity Relationship

2019